Jeremy Labrecque

Latest

• 3.31 Hypothetical Interventions to Reduce Behavior Problems in Children Born after an Unintended Pregnancy: The Generation R Study
• From Complexity to Clarity: How Directed Acyclic Graphs Enhance the Study Design of Systematic Reviews and Meta-Analyses
• Impact of Waiting Time on Post-Transplant Survival for Recipients with Hepatocellular Carcinoma: A Natural Experiment Randomized by Blood Group
• Lipoprotein (a) and Progression of Aortic Valve Calcification: A Case of Collider Bias? Reply
• Attention-Deficit Hyperactivity Disorder Symptoms and Brain Morphology: Examining Confounding Bias
• Plasma microRNA Signature of Alcohol Consumption: The Rotterdam Study
• Prenatal Smoking, Alcohol and Caffeine Exposure and Maternal-Reported Attention Deficit Hyperactivity Disorder Symptoms in Childhood: Triangulation of Evidence Using Negative Control and Polygenic Risk Score Analyses
• Application of the Instrumental Inequalities to a Mendelian Randomization Study with Multiple Proposed Instruments
• Causal Null Hypotheses of Sustained Treatment Strategies: What Can Be Tested with an Instrumental Variable?
• Conditional Cash Transfers and Child Health
• Focus and Coverage of Bolsa Família Program in the Pelotas 2004 Birth Cohort
• Malignancy in Pediatric-Onset Systemic Lupus Erythematosus
• Malignancy Incidence in 5294 Patients with Juvenile Arthritis
• Cancer Risk in Childhood-Onset Systemic Lupus.
• Cancer Risk in Systemic Lupus: An Updated International Multi- Centre Cohort Study
• Estimating Health-Selective Migration in Patients with Rheumatoid Arthritis Using Administrative Data
• Systematic Review and Critical Appraisal of Validation Studies to Identify Rheumatic Diseases in Health Administrative Databases
• A Population-Based Assessment of Live Births in Women with Systemic Lupus Erythematosus.
• Alberta's First Nations Community Is Not at Increased Risk of Inflammatory Myopathy: Population-based Prevalence Estimates Using Administrative Databases
• Cancer in Pediatric-Onset Systemic Lupus: What Is the Role of Disease Duration and Other Factors on Risk?: 2475
• Prevalence of Autoimmune Inflammatory Myopathy in the First Nations Population of Alberta, Canada
• Prevalence of Systemic Lupus Erythematosus and Systemic Sclerosis in the First Nations Population of Alberta, Canada
• A Systematic Review to Evaluate the Quality and Reporting of Administrative Database Validation Studies for Rheumatic Diseases
• Cancer Risk in Pediatric Systemic Lupus: Updated Analyses
• Is the Heightened Lung Cancer Risk in Systemic Lupus Erythematosus Decreasing over Time? Data from a Very Large International Multi-Centre Cohort
• Malignancies in Juvenile Idiopathic Arthritis: A Preliminary Report
• Malignancy and JIA: Updated Results
• Population-Based Prevalence Estimates of Myositis in First Nations Relative to Non-First Nations Canadians
• Scleroderma Prevalence in Alberta: A Population-Based Assessment
• The Prevalence of Systemic Autoimmune Rheumatic Diseases in Canadian Pediatric Populations: Administrative Database Estimates
• The Prevalence of Systemic Lupus in Alberta: A Population-Based Assessment
• A Population-Based Ecological Investigation of the Relationship between Road Density and Systemic Autoimmune Rheumatic Disease Prevalence
• Preliminary Analyses of Spatial Clustering of the Prevalence of Systemic Autoimmune Rheumatic Diseases in Montreal, Quebec
• Systemic Lupus Erythematosus in Nova Scotia, Canada
• Indicator Species of Soil Nutrients and Poplar Plantation Productivity in Southeastern Quebec